Living with Huntington's disease (HD) presents unique challenges, affecting movement, thinking, and behavior. If you or a loved one has received an HD diagnosis, understanding the available treatment options is a crucial step in navigating this journey. While there is currently no cure for Huntington's disease, significant progress has been made in managing its diverse symptoms and improving the quality of life for those affected.

This article explores the current approaches to managing HD symptoms, drawing on insights from recent research and clinical experience.

Understanding Huntington's Disease and Its Impact

Huntington's disease is a progressive neurodegenerative disorder caused by a genetic mutation. Symptoms typically develop gradually and worsen over time. These symptoms can vary widely from person to person but commonly include:

Motor symptoms: Involuntary movements (chorea) are often the most recognizable sign, but other movement difficulties like stiffness, slow movements (bradykinesia), balance problems, and dystonia can also occur.
Cognitive symptoms: Changes in thinking, memory, judgment, and problem-solving abilities.
Psychiatric and behavioral symptoms: Mood swings, depression, anxiety, irritability, apathy, and sometimes psychotic symptoms.

These symptoms can significantly impact daily life, making activities like walking, talking, swallowing, and managing emotions more challenging.

The Goal of Huntington's Disease Treatment: Symptom Management

Since there is no treatment yet available to stop or reverse the progression of HD, the primary focus of care is on managing symptoms and supporting individuals to maintain the best possible quality of life and functional independence for as long as possible. (Stoker et al., 2022; Roos, 2010)

Treatment plans are highly individualized, tailored to the specific symptoms a person is experiencing and how the disease is affecting them. This often involves a combination of approaches.

Medications for Symptom Control

Medications play a vital role in managing many of the challenging symptoms of HD. (Supporting Info 2)

Managing Involuntary Movements (Chorea): For the characteristic involuntary jerking or writhing movements known as chorea, medications can help reduce their severity. According to guidelines from the German Neurological Society published in 2023, medications like tiapride and tetrabenazine are often considered first-line treatments. (Saft et al., 2023; Roos, 2010) Other medications, including antipsychotics like risperidone or olanzapine, may also be used, sometimes offering additional benefits like improving irritability or sleep. (Saft et al., 2023) Finding the right medication and dosage often requires careful adjustment under medical supervision, as these medications can sometimes have side effects.
Addressing Psychiatric and Behavioral Symptoms: Mood and behavioral changes can be among the earliest and most challenging symptoms of HD. (Loi et al., 2018) Antidepressants, mood stabilizers, and antipsychotic medications may be prescribed to help manage depression, anxiety, irritability, aggression, and psychotic features. (Saft et al., 2023) Early recognition and treatment of these symptoms are essential for improving well-being.
Treating Other Complications: Medications may also be used to address other issues that can arise, such as sleep disturbances or other physical complications.

Beyond Medication: Supportive Therapies

While medications are important, non-pharmacological therapies are equally crucial in managing HD symptoms and improving daily function. These therapies focus on helping individuals adapt to changes and maintain independence.

Physical Therapy: Helps with movement difficulties, balance, coordination, and gait, aiming to maintain mobility and reduce the risk of falls.
Occupational Therapy: Provides strategies and tools to help individuals perform daily activities like dressing, eating, and personal hygiene. They can also assess the home environment and recommend modifications for safety and ease of movement.
Speech and Language Therapy: Assists with communication challenges, including slurred speech (dysarthria), and provides strategies for safer swallowing (dysphagia), which is important for maintaining nutrition and preventing aspiration.
Nutrition Support: A dietitian can help create meal plans to maintain weight, especially important as involuntary movements can burn many calories. They also provide guidance on food textures and strategies for safe eating when swallowing becomes difficult.
Psychological Counseling and Support: Provides emotional support, coping strategies, and counseling for individuals with HD and their families to navigate the psychological impact of the disease.

The Importance of Multidisciplinary Care

Given the complex and varied symptoms of Huntington's disease, the most effective approach to care involves a team of healthcare professionals working together. (Supporting Info 3; Roos, 2010; Mühlbӓck et al., 2023; Edmondson & Goodman, 2017) This "multidisciplinary team" may include:

Neurologists specializing in HD or movement disorders
Psychiatrists
Physical, occupational, and speech therapists
Social workers
Genetic counselors
Dietitians
Psychologists
Case managers or care coordinators

A multidisciplinary team ensures that all aspects of the disease – motor, cognitive, and psychiatric – are addressed in a coordinated manner. This collaborative approach helps tailor treatment plans, anticipates potential challenges, and provides comprehensive support to both the patient and their family or caregivers. (Mühlbӓck et al., 2023)

Palliative Care: Focusing on Quality of Life

Palliative care is an important component of HD management throughout the disease course, not just in the final stages. This specialized care focuses on providing relief from the symptoms and stress of a serious illness. The goal is to improve quality of life for both the patient and the family by addressing physical, psychological, social, and spiritual needs. (Mestre & Shannon, 2017)

Looking Towards the Future

While current treatments focus on managing symptoms, the scientific community is actively researching therapies that could potentially slow or stop the progression of HD. Promising areas of research include strategies aimed at lowering the levels of the harmful huntingtin protein, such as antisense oligonucleotide therapies and other genetic or epigenetic manipulations. (Kim et al., 2021; Tabrizi et al., 2022; Andhale & Shrivastava, 2022; Ghosh & Tabrizi, 2018; McColgan & Tabrizi, 2018) Clinical trials for these potential disease-modifying treatments are ongoing, offering hope for future breakthroughs.

Conclusion

Living with Huntington's disease is a challenging journey, but effective management strategies can make a significant difference in the lives of affected individuals and their families. By focusing on comprehensive symptom management through medications, supportive therapies, and particularly a coordinated multidisciplinary care team, it is possible to enhance quality of life and support individuals in maintaining function and dignity. Staying informed and working closely with healthcare professionals are key steps in navigating the complexities of HD care.

References

Andhale, R., & Shrivastava, D. (2022). Huntington's Disease: A Clinical Review. Cureus, 14(10), e30692. doi:10.7759/cureus.30692
Edmondson, M. C., & Goodman, L. (2017). Contemporary health care for Huntington disease. Handbook of Clinical Neurology, 144, 387-398. doi:10.1016/B978-0-12-801893-4.00027-7
Ghosh, R., & Tabrizi, S. J. (2018). Clinical Features of Huntington's Disease. In S. J. Tabrizi (Ed.), Huntington's Disease: Pathogenesis and Therapeutics (pp. 1–23). Springer. doi:10.1007/978-3-319-27369-1_1-2
Kim, A., Lalonde, K., Truesdell, A., Welter, P. G., Brocardo, P. S., Rosenstock, T. R., & Gil-Mohapel, J. (2021). New Avenues for the Treatment of Huntington's Disease. Frontiers in Aging Neuroscience, 13, 785150. doi:10.3389/fnagi.2021.785150
Loi, S. M., Walterfang, M., Velakoulis, D., & Looi, J. C. L. (2018). Huntington's disease: Managing neuropsychiatric symptoms in Huntington's disease. Australasian Psychiatry, 26(6), 619-622. doi:10.1177/1039856218795184
McColgan, P., & Tabrizi, S. J. (2018). Huntington's disease: a clinical review. European Journal of Neurology, 25(1), 24-34. doi:10.1111/ene.13303
Mestre, T. A., & Shannon, K. (2017). Huntington disease care: From the past to the present, to the future. Journal of the Neurological Sciences, 383, 159-162. doi:10.1016/j.jns.2017.10.020
Mühlbӓck, A., van Walsem, M., Nance, M., Arnesen, A., Page, K., Fisher, A., ... & European Huntington’s Disease Network Multidisciplinary Care and Treatment Working Group. (2023). What we don't need to prove but need to do in multidisciplinary treatment and care in Huntington's disease: a position paper. Orphanet Journal of Rare Diseases, 18(1), 121. doi:10.1186/s13023-023-02729-x
Roos, R. A. C. (2010). Huntington's disease: a clinical review. Orphanet Journal of Rare Diseases, 5, 40. doi:10.1186/1750-1172-5-40
Saft, C., Burgunder, J. M., Dose, M., Jung, H. H., Katzenschlager, R., Priller, J., ... & Landwehrmeyer, G. B. (2023). Symptomatic treatment options for Huntington's disease (guidelines of the German Neurological Society). Orphanet Journal of Rare Diseases, 18(1), 318. doi:10.1186/s13023-023-02929-0
Stoker, T. B., Mason, S. L., Greenland, J. C., Holden, S. T., Santini, H., & Barker, R. A. (2022). Huntington's disease: diagnosis and management. Practical Neurology, 22(6), 476-485. doi:10.1136/pn-2022-003536
Tabrizi, S. J., Estevez-Fraga, C., van Roon-Mom, W. M. C., Flower, M. D., Scahill, R. I., Wild, E. J., ... & Leavitt, B. R. (2022). Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities. The Lancet. Neurology, 21(7), 645-658. doi:10.1016/S1474-4422(22)00121-X

Managing Huntington’s Disease: Treatments and Therapies You Should Know